Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker EVMN
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 12, 2026 | EVMN Evommune, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 12, 2026 | EVMN Evommune, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 5, 2026 | EVMN Evommune, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 4, 2026 | EVMN Evommune, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 4, 2026 | EVMN Evommune, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 4, 2026 | EVMN Evommune, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Nov 4, 2026 | EVMN Evommune, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Oct 1, 2026 | EVMN Evommune, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 23, 2026 | EVMN Evommune, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 15, 2026 | EVMN Evommune, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 9, 2026 | EVMN Evommune, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Sep 9, 2026 | EVMN Evommune, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 6, 2026 | EVMN Evommune, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 30, 2026 | EVMN Evommune, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 29, 2026 | EVMN Evommune, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 29, 2026 | EVMN Evommune, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 2, 2026 | EVMN Evommune, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 7, 2026 | EVMN Evommune, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 7, 2026 | EVMN Evommune, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 13, 2026 | EVMN Evommune, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 5, 2026 | EVMN Evommune, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 13, 2026 | EVMN Evommune, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 13, 2026 | EVMN Evommune, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Feb 13, 2026 | EVMN Evommune, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Feb 10, 2026 | EVMN Evommune, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 11, 2025 | EVMN Evommune, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 7, 2025 | EVMN Evommune, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
27 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:48 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances